← All trials
NCT06249191
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 13, 2024
- Primary completion
- Apr 1, 2026
- Completion date
- Apr 1, 2027
- First posted
- Feb 8, 2024
- Last posted
- Jul 23, 2024
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- OHSU Knight Cancer InstituteLead sponsor
- OHSU Knight Cancer InstituteSponsor investigator
- OHSU Knight Cancer InstituteOfficial
- Oregon Health and Science UniversityCollaborator
- GenentechCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.